清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.

医学 吉西他滨 化疗 诱导化疗 顺铂 阶段(地层学) 内科学 外科 肿瘤科 紫杉醇 胃肠病学 生物 古生物学
作者
Sung Hoon Choi,Beodeul Kang,Jaekyung Cheon,Hongjae Chon,Dae Jung Kim,Chang‐Il Kwon,Kwang Hyun Ko
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:40 (4_suppl): 387-387
标识
DOI:10.1200/jco.2022.40.4_suppl.387
摘要

387 Background: In a recent phase II trial, nab-paclitaxel plus gemcitabine-cisplatin (Gem/Cis/nab-P) demonstrated prolonged survival and unprecedentedly high response rate in patients with advanced cholangiocarcinoma following treatment. We aimed to evaluate the clinical feasibility of this triplet chemotherapy as induction chemotherapy in patients with locally advanced cholangiocarcinoma. Methods: We retrospectively reviewed patients with locally advanced cholangiocarcinoma who were treated with Gem/Cis/nab-P between October 2019 to December 2020. Resectability after induction chemotherapy was evaluated by a multidisciplinary team. Treatment response and surgical pathology were reviewed. Results: Of the 85 patients were included in this study. 46 (54.1%) had measurable lesions. The objective response rate (ORR) and disease control rate in patients with measurable disease were 51.1% and 85.1%, respectively. Fifty-two (61.2%) patients were determined as resectable. Four patients that were judged to be resectable did not undergo surgery due to patient refusal or poor performance status after chemotherapy. Finally, 48 out of 85 patients (56.5%) underwent subsequent curative surgery after induction chemotherapy. There were six complete remission cases (12.5%) in the final pathology, which all reported patients with extrahepatic cholangiocarcinoma. R0 resection was achieved in 46 out of the 48 patients (95.8%). Despite the initial locally advanced cholangiocarcinoma, a pathologic T stage of less than T2 was reported in 44 (95.7%) patients. Lymph node metastasis was confirmed in 13 (27.1%) patients. The overall survival rates in patients who had chemotherapy followed by surgery was better than in those treated with chemotherapy alone ( P = 0.009). Conclusions: Gem/Cis/nab-P as induction chemotherapy showed promising efficacy and clinical feasibility before curative surgery in patients with locally advanced cholangiocarcinoma. This study showed that triplet chemotherapy using Gem/Cis/nab-P has a clear down-staging effect through a high response rate in patients with cholangiocarcinoma
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
手帕很忙完成签到,获得积分10
13秒前
铜豌豆完成签到 ,获得积分10
13秒前
652183758完成签到 ,获得积分10
17秒前
gmc完成签到 ,获得积分10
17秒前
xianyaoz完成签到 ,获得积分10
18秒前
GIPCY完成签到 ,获得积分10
22秒前
洁净的盼易完成签到 ,获得积分10
24秒前
芝诺的乌龟完成签到 ,获得积分0
26秒前
NN完成签到,获得积分10
29秒前
Richardisme完成签到 ,获得积分10
30秒前
丹青完成签到 ,获得积分10
33秒前
魔幻的慕梅完成签到 ,获得积分10
34秒前
慧慧子完成签到 ,获得积分10
34秒前
croissante完成签到 ,获得积分10
36秒前
现代的含雁完成签到 ,获得积分10
43秒前
wpybird完成签到,获得积分10
51秒前
Jemezs完成签到,获得积分10
54秒前
马登完成签到,获得积分10
56秒前
梅啦啦完成签到 ,获得积分10
56秒前
1分钟前
wyt发布了新的文献求助10
1分钟前
1分钟前
北笙完成签到 ,获得积分10
1分钟前
1分钟前
陈龙平完成签到 ,获得积分10
1分钟前
小羊咩完成签到 ,获得积分10
1分钟前
研友_ZbP41L完成签到 ,获得积分10
1分钟前
穆一手完成签到 ,获得积分10
1分钟前
八戒完成签到 ,获得积分10
1分钟前
LT完成签到 ,获得积分10
1分钟前
冰留完成签到 ,获得积分10
1分钟前
ommphey完成签到 ,获得积分10
1分钟前
kaka完成签到,获得积分0
1分钟前
婉莹完成签到 ,获得积分0
1分钟前
智智完成签到 ,获得积分10
1分钟前
veggieg完成签到,获得积分10
2分钟前
孟寐以求完成签到 ,获得积分10
2分钟前
大喜子完成签到 ,获得积分10
2分钟前
wbb完成签到 ,获得积分10
2分钟前
Skywalk满天星完成签到,获得积分10
2分钟前
高分求助中
Sustainability in Tides Chemistry 1500
Handbook of the Mammals of the World – Volume 3: Primates 805
拟南芥模式识别受体参与调控抗病蛋白介导的ETI免疫反应的机制研究 550
Gerard de Lairesse : an artist between stage and studio 500
Digging and Dealing in Eighteenth-Century Rome 500
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Manual of Sewer Condition Classification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3068255
求助须知:如何正确求助?哪些是违规求助? 2722176
关于积分的说明 7476072
捐赠科研通 2369142
什么是DOI,文献DOI怎么找? 1256228
科研通“疑难数据库(出版商)”最低求助积分说明 609518
版权声明 596835